Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Trevi Therapeutics, Inc. | 675,000 | reported | 19 Feb 2026 | tx 41+4,153,056−325,078 |
| RHYTHM PHARMACEUTICALS, INC. | 7,037 | reported | 24 Jun 2025 | tx 39+220,749−174,000 |
| PENWEST PHARMACEUTICALS CO | 0 | reported | 20 Sept 2010 | tx 19+704,500−427,994 |
| COLUMBIA LABORATORIES INC | 0 | reported | 14 Aug 2018 | tx 2+15,000−15,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 Feb 2026 | GRANT_AWARD | Trevi Therapeutics, Inc. | 675,000 | 0.00 USD | deriv |
| 24 Jun 2025 | GRANT_AWARD | RHYTHM PHARMACEUTICALS, INC. | 7,037 | 0.00 USD | deriv |
| 24 Jun 2025 | GRANT_AWARD | RHYTHM PHARMACEUTICALS, INC. | 4,712 | 0.00 USD | deriv |
| 18 Jun 2025 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 4,000 | — | |
| 18 Jun 2025 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 4,000 | 0.00 USD | deriv |
| 31 May 2025 | GRANT_AWARD | Trevi Therapeutics, Inc. | 102,000 | 0.00 USD | deriv |
| 21 Mar 2025 | EXERCISE | Trevi Therapeutics, Inc. | 5,263 | 1.43 USD | |
| 21 Mar 2025 | SALE | Trevi Therapeutics, Inc. | 5,263 | 6.58 USD | |
| 21 Mar 2025 | EXERCISE | Trevi Therapeutics, Inc. | 5,263 | 0.00 USD | deriv |
| 10 Mar 2025 | GRANT_AWARD | Trevi Therapeutics, Inc. | 54,400 | 0.00 USD | deriv |
| 18 Feb 2025 | GRANT_AWARD | Trevi Therapeutics, Inc. | 811,000 | 0.00 USD | deriv |
| 17 Sept 2024 | SALE | RHYTHM PHARMACEUTICALS, INC. | 31,751 | 52.40 USD | |
| 17 Sept 2024 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 15,000 | 22.93 USD | |
| 17 Sept 2024 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 9,250 | 21.37 USD | |
| 17 Sept 2024 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 7,501 | 18.99 USD | |
| 17 Sept 2024 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 9,250 | 0.00 USD | deriv |
| 17 Sept 2024 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 7,501 | 0.00 USD | deriv |
| 17 Sept 2024 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 15,000 | 0.00 USD | deriv |
| 09 Sept 2024 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 1,736 | 18.99 USD | |
| 09 Sept 2024 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 4,305 | 21.37 USD | |
| 09 Sept 2024 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 12,900 | 22.93 USD | |
| 09 Sept 2024 | SALE | RHYTHM PHARMACEUTICALS, INC. | 37,241 | 50.45 USD | |
| 09 Sept 2024 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 18,300 | 4.15 USD | |
| 09 Sept 2024 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 18,300 | 0.00 USD | deriv |
| 09 Sept 2024 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 4,305 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 09 May 2019.